Modulating the Release Kinetics of Natural Product Actinomycin from Bacterial Nanocellulose Films and Their Antimicrobial Activity
-
Published:2024-08-19
Issue:8
Volume:11
Page:847
-
ISSN:2306-5354
-
Container-title:Bioengineering
-
language:en
-
Short-container-title:Bioengineering
Author:
Zimowska Katarzyna1, Filipovic Vuk1, Nikodinovic-Runic Jasmina1ORCID, Simic Jelena1ORCID, Ilic-Tomic Tatjana1, Zimowska Malgorzata2ORCID, Gurgul Jacek2, Ponjavic Marijana1ORCID
Affiliation:
1. Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Vojvode Stepe 444a, 11042 Belgrade, Serbia 2. Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, Niezapominajek 8, 30-239 Krakow, Poland
Abstract
The present study aimed to create a more sustainable and controlled delivery system based on natural biopolymer bacterial nanocellulose (BNC) and bacterial natural product actinomycin (Act), with the applicative potential in the biomedical field. In order to provide improved interaction between BNC and the active compound, and thus to modulate the release kinetics, the TEMPO oxidation of BNC support was carried out. A mix of actinomycins from bacterial fermentation (ActX) were used as natural antimicrobial agents with an established bioactivity profile and clinical use. BNC and TEMPO-oxidized BNC films with incorporated active compounds were obtained and analyzed by FTIR, SEM, XPS, and XRD. The ActX release profiles were determined in phosphate-buffer solution, PBS, at 37 °C over time. FTIR analysis confirmed the improved incorporation and efficiency of ActX adsorption on oxidized BNC due to the availability of more active sites provided by oxidation. SEM analysis indicated the incorporation of ActX into the less-dense morphology of the TEMPO-oxidized BNC in comparison to pure BNC. The release kinetics of ActX were significantly affected by the BNC structure, and the activated BNC sample indicated the sustained release of active compounds over time, corresponding to the Fickian diffusion mechanism. Antimicrobial tests using Staphylococcus aureus NCTC 6571 confirmed the potency of this BNC-based system for biomedical applications, taking advantage of the capacity of modified BNC to control and modulate the release of bioactive compounds.
Funder
Science Fund of the Republic of Serbia, IDEJE BioECOLogics Ministry of Science, Technological Development and Innovations of the Republic of Serbia Erasmus+ Programme
Reference67 articles.
1. Samyn, P., Meftahi, A., Geravand, S.A., Heravi, M.E.M., Najarzadeh, H., Sabery, M.S.K., and Barhoum, A. (2023). Opportunities for bacterial nanocellulose in biomedical applications: Review on biosynthesis, modification and challenges. Int. J. Biol. Macromol., 231. 2. Recent Developments in Bacterial Nanocellulose Production and its Biomedical Applications;Chandana;J. Polym. Environ.,2022 3. Advanced biotechnological applications of bacterial nanocellulose-based biopolymer nanohybrids: A review;Ullah;Adv. Ind. Eng. Polym. Res.,2024 4. Sourkouni, G., Jeremić, S., Kalogirou, C., Höfft, O., Nenadovic, M., Jankovic, V., Rajasekaran, D., Pandis, P., Padamati, R., and Nikodinovic-Runic, J. (2023). Study of PLA pre-treatment, enzymatic and model-compost degradation, and valorization of degradation products to bacterial nanocellulose. World J. Microbiol. Biotechnol., 39. 5. Biotechnological model for ubiquitous mixed petroleum- and bio-based plastics degradation and upcycling into bacterial nanocellulose;Araujo;J. Clean. Prod.,2024
|
|